These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20859217)

  • 1. Effectiveness of mycophenolic acid in refractory pyoderma gangrenosum.
    Husein-ElAhmed H; Callejas-Rubio JL; Ríos Fernandez R; Ortego Centeno N
    J Clin Rheumatol; 2010 Oct; 16(7):346-7. PubMed ID: 20859217
    [No Abstract]   [Full Text] [Related]  

  • 2. The Management of Peristomal Pyoderma Gangrenosum in IBD.
    O'Brien SJ; Ellis CT
    Dis Colon Rectum; 2020 Jul; 63(7):881-884. PubMed ID: 32496328
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.
    Daniels NH; Callen JP
    Arch Dermatol; 2004 Dec; 140(12):1427-9. PubMed ID: 15611417
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature.
    González-Moreno J; Ruíz-Ruigomez M; Callejas Rubio JL; Ríos Fernández R; Ortego Centeno N
    Lupus; 2015 Feb; 24(2):130-7. PubMed ID: 25199808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum Preceding the diagnosis of systemic lupus erythematosus.
    Waldman MA; Callen JP
    Dermatology; 2005; 210(1):64-7. PubMed ID: 15604550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.
    Schmid MH; Hary C; Marstaller B; Konz B; Wendtner CM
    Eur J Dermatol; 1998; 8(1):45-7. PubMed ID: 9649713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil.
    Le Hello C; Bonte I; Mora JJ; Verneuil L; Noël LH; Guillevin L
    Rheumatology (Oxford); 2002 Feb; 41(2):236-7. PubMed ID: 11886982
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC; Lynch W; Anhalt GJ; Petri M
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases.
    Masatlioğlu SP; Göktay F; Mansur AT; Akkaya AD; Güneş P
    Rheumatol Int; 2009 May; 29(7):837-40. PubMed ID: 19043716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyoderma gangrenosum in dorsum of right foot].
    Husein-Elahmed H; Aneiros-Fernández J; Arias-Santiago S; Gutiérrez-Salmerón MT; Naranjo-Sintes R
    Med Clin (Barc); 2011 May; 136(15):700. PubMed ID: 20189200
    [No Abstract]   [Full Text] [Related]  

  • 11. An enlarging ulcer.
    Micheletti R; Fett N
    Am J Med; 2011 Oct; 124(10):915-7. PubMed ID: 21962310
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients.
    Beynon C; Chin MF; Hunasehally P; Bhagwandas K; Bevan M; Taylor M; Lawson T
    J Clin Rheumatol; 2017 Apr; 23(3):181-183. PubMed ID: 28333874
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T; Hashimoto T; Furukawa F
    Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum associated with biphenotypic acute leukemia.
    Asai M; Aragane Y; Kawada A; Shimada T; Kanamaru A; Yamada H; Tezukam T
    J Am Acad Dermatol; 2001 Mar; 44(3):530-1. PubMed ID: 11209130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus and leg ulcers--a diagnostic quandary.
    Reddy V; Dziadzio M; Hamdulay S; Boyce S; Prasad N; Keat A
    Clin Rheumatol; 2007 Jul; 26(7):1173-5. PubMed ID: 16633706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid improvement of pyoderma gangrenosum after treatment with infliximab.
    Chan JL; Graves MS; Cockerell CJ; Pandya AG
    J Drugs Dermatol; 2010 Jun; 9(6):702-4. PubMed ID: 20645536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus.
    Roger D; Aldigier JC; Peyronnet P; Bonnetblanc JM; Leroux-Robert C
    Clin Exp Dermatol; 1993 May; 18(3):268-70. PubMed ID: 8348724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of repeated pyoderma gangrenosum with myelodysplastic syndrome].
    Aoki M; Miura A; Sato I; Suzuki C
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):117-9. PubMed ID: 8459158
    [No Abstract]   [Full Text] [Related]  

  • 20. Ulcerative pyoderma gangrenosum.
    Sander M; Sander M
    CMAJ; 2019 Sep; 191(38):E1058. PubMed ID: 31548193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.